Хайлтын үр дүнгүүд - Haolan Lu

  • 4-н 1 - 4 үр дүнгүүдийг харуулж байна
Үр дүнг сайжруулах
  1. 1
    Ipilimumab in Combination With Paclitaxel and Carboplatin As First-Line Treatment in Stage IIIB/IV Non–Small-Cell Lung Cancer: Results From a Randomized, Double-Blind, Multicenter Phase II Study

    Ipilimumab in Combination With Paclitaxel and Carboplatin As First-Line Treatment in Stage IIIB/IV Non–Small-Cell Lung Cancer: Results From a Randomized, Double-Blind, Multicenter... -н Thomas J. Lynch, Igor Bondarenko, Alexander Luft, Piotr Serwatowski, Fabrice Barlési, Raju Titus Chacko, Martin Sebastian, Joel W. Neal, Haolan Lu, Jean-Marie Cuillerot, Martin Reck

    Хэвлэсэн 2012
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  2. 2
    <scp>First-in-Human</scp> Phase I Study of Envafolimab, a Novel Subcutaneous <scp>Single-Domain Anti-PD-L1</scp> Antibody, in Patients with Advanced Solid Tumors

    <scp>First-in-Human</scp> Phase I Study of Envafolimab, a Novel Subcutaneous <scp>Single-Domain Anti-PD-L1</scp> Antibody, in Patients with Advanced Solid Tumors -н Kyriakos P. Papadopoulos, Wael A. Harb, Cody J. Peer, Qiong Hua, Siying Xu, Haolan Lu, Ni Lu, Yue He, Ting Xu, Rui-Ping Dong, John Gong, David Liu

    Хэвлэсэн 2021
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  3. 3
    Subcutaneous envafolimab monotherapy in patients with advanced defective mismatch repair/microsatellite instability high solid tumors

    Subcutaneous envafolimab monotherapy in patients with advanced defective mismatch repair/microsatellite instability high solid tumors -н Jian Li, Yanhong Deng, Weijie Zhang, Aiping Zhou, Weijian Guo, Jianwei Yang, Ying Yuan, Liangjun Zhu, Shukui Qin, Silong Xiang, Haolan Lu, John Gong, Ting Xu, David Liu, Lin Shen

    Хэвлэсэн 2021
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  4. 4
    OA03.05 Analysis of Early Survival in Patients with Advanced Non-Squamous NSCLC Treated with Nivolumab vs Docetaxel in CheckMate 057

    OA03.05 Analysis of Early Survival in Patients with Advanced Non-Squamous NSCLC Treated with Nivolumab vs Docetaxel in CheckMate 057 -н Solange Peters, Federico Cappuzzo, Leora Horn, Luis Paz‐Ares, Hossein Borghaei, Fabrice Barlési, Martin Steins, Enriqueta Felip, David R. Spigel, Cécile Dorange, Haolan Lu, Diane Healey, Teresa Kong Sanchez, Prabhu Bhagavatheeswaran, James Novotny, Brian Lestini, Julie R. Brahmer

    Хэвлэсэн 2017
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:

Хайх хэрэгслүүд: